The cost of shock resuscitation treatment decisions

Affiliations

Comment

Michael R Pinsky. Lancet Respir Med. 2016 Oct.

. 2016 Oct;4(10):769-770.

doi: 10.1016/S2213-2600(16)30140-0. Epub 2016 Jun 17.

¹ Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA. Electronic address: pinsky@pitt.edu.

No abstract available

Comment on

Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long-term outcomes and cost-effectiveness analysis of a cohort from CHEST.
Taylor C, Thompson K, Finfer S, Higgins A, Jan S, Li Q, Liu B, Myburgh J; Crystalloid versus Hydroxyethyl Starch Trial (CHEST) investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Taylor C, et al. Lancet Respir Med. 2016 Oct;4(10):818-825. doi: 10.1016/S2213-2600(16)30120-5. Epub 2016 Jun 17. Lancet Respir Med. 2016. PMID: 27324967 Clinical Trial.